Early Access — free while we kick the tires
EdgarHawk

Zimpfer Matthew J.

General Counsel

Officer
3 filings analyzed · 1 company · Latest 2026-02-18

Never miss a filing from Zimpfer Matthew J.

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
CNO Financial Group, Inc. CNO 0 11 Net selling

Activity

February 2026
medium
Sell
57,370 shares
$2,472,554
Significance 6/10

CNO General Counsel Matthew J. Zimpfer sold 57,370 shares for $2,472,553.89 at average $43.10 on Feb 17–18.

Zimpfer executed 2 separate sales totaling 57,370 shares for $2,472,553.89, reducing his holdings from 365,307 shares to 307,937 shares (-15.7%). This represents his third open-market sale at CNO within a month—he sold again on 2026-02-12, just five days prior. His prior 2 measurable sales at CNO occurred on 2025-02-19 and 2025-02-21; both showed negative 90-day returns of -1.2% and -7.1% respectively, meaning he sold before subsequent declines. At the cross-ticker level, his track record across 3 prior sales shows a 100.00% well-timed rate at the 90-day mark. The current stock price of $43.04 sits near the blended sale price of $43.10, placing it near 52-week highs and +8.2% over 90 days. The timing of consecutive sales within days, combined with his prior pattern of selling before downturns at this ticker, may warrant observation of subsequent price action.

medium
Sell
30,970 shares
$1,329,582
Significance 5/10

CNO General Counsel Zimpfer sells 30,970 shares at $42.93; prior two CNO sells both delivered negative 90-day returns.

Matthew J. Zimpfer, General Counsel of CNO Financial Group, sold 30,970 shares (31.0K shares) on 2026-02-12 at $42.93, reducing holdings by 9.1% to 307.9K shares. His prior two open-market sales at CNO (on 2025-02-21 and 2025-02-19) both posted negative 90-day returns (-7.1% and -5.4%), establishing a 2-of-2 pattern of well-timed exits. At the current price of $43.20, the stock trades 3.2% below its 52-week high and 4.8% above its 90-day level, suggesting modest upside momentum into early February. The company's fundamentals remain solid with 7.3% annual revenue growth and a P/E of 13.63, but Zimpfer's consistent prior timing of sales before CNO declines deserves attention as a potential leading indicator of near-term weakness.

February 2025
medium
Sell
81,600 shares
$3,329,182
Significance 5/10

CNO General Counsel Zimpfer sells 81.6K shares in 2 transactions for $3.3M at $40.80 avg; retains 204.1K shares

General Counsel Matthew J. Zimpfer executed 2 separate sales totaling 81,600 shares for $3,329,182.08, reducing his holdings by 28.6% from 285,743 shares to 204,143 shares post-transaction. The sales were executed at $41.49 on 2025-02-19 and $40.10 on 2025-02-21, near the stock's 52-week high of $41.69, as the company trades at a P/E of 14.96 with annual revenue growth of 15.9%. The magnitude of the reduction is material, though Zimpfer maintains a substantial remaining position of 204.1K shares, indicating continued meaningful ownership and alignment with shareholders.

Related insiders